过去一年中添加的文章，按日期排序
… inhibitor treatment versus neutralizing monoclonal antibody therapy in COVID-19 outpatients: a multi-center, non-inferiority, open-label randomized controlled trial …
T Siripongboonsitti, N Nontawong… - Microbiology …, 2023 - Am Soc Microbiol
235 天前 - … variants, favipiravir (FPV) has been extensively deployed as the standard treatment
for mild-to-moderate cases of COVID-19, adhering to the Thai COVID-19 clinical practice …
for mild-to-moderate cases of COVID-19, adhering to the Thai COVID-19 clinical practice …